Change in cellular localization of a rheumatoid arthritis-related antigen (RA-A47) with downregulation upon stimulation by inflammatory cytokines in chondrocytes

Journal of Cellular Physiology

Volumn 186, Issue 2, 2001, Pages 168-281

  Hattori, Takako ^a   Kubota, Satoshi ^a   Yutani, Yasutaka ^b   Fujisawa, Takuo ^a   Nakanishi, Tohru ^a   Takahashi, Kojiro ^a,c   Takigawa, Masaharu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b School of Medicine   (Japan)

^c HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BETA INTERFERON; COLLAGEN TYPE 2; COMPLEMENTARY DNA; CYTOKINE; HEAT SHOCK PROTEIN 47; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; RHEUMATOID ARTHRITIS RELATED ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; CARTILAGE CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

EID: 0035149654     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200002)186:2<168::aid-jcp1022>3.0.co;2-m     Document Type: Article

References (75)

1. The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study
2. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
3. Rheumatoid arthritis: Current concepts
4. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis
5. Interleukin-1, tumor necrosis factor and their specific inhibitors
6. Effects of tumor necrosis factor alpha on proliferation and expression of differentiated phenotypes in rabbit costal chondrocytes in culture
7. Rheumatoid arthritis: Etiopathogenetic considerations
8. Rheumatoid arthritis
9. Interplay of T lymphocytes and HLA-DR molecules in rheumatoid arthritis
10. Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis
11. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis
12. Isolation and characterization of a rheumatoid arthritis-specific antigen (RA-A47) from a human chondrocytic cell line (HCS-2/8)
13. Rheumatoid arthritis related antigen 47 kDa (RA-A47) is a product of colligin-2 and acts as a human HSP47
14. Cell surface colligin/Hsp47 associates with tetraspanin protein CD9 in epidermoid carcinoma cell lines
15. Progression of articular destruction and the production of tumour necrosis factor-alpha in antigen-induced arthritis in rabbits
16. Immunity in rheumatoid arthritis
17. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis
18. Expression of heat-shock protein 47 in mouse liver
19. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity
20. Synovial class II antigen expression and immune complex formation in rheumatoid arthritis
21. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis- related molecules
22. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
23. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
24. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis
25. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity
26. Etiology of rheumatoid arthritis
27. Rheumatoid arthritis: Clinical features and pathogenetic mechanisms
28. Involvement of cis-acting repressive element(s) in the 3′-untranslated region of human connective tissue growth factor gene
29. Cell surface-associated proteins which bind native Type IV collagen and gelatin
30. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Quantitative zymography of matrix metalloproteinases by measuring hydroxyproline: Application to gelatinases A and B
33. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes
34. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis
35. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease
36. Cartilage oligomeric matrix protein (COMP): The role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis
37. Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis
38. HSP47: A collagen specific molecular chaperone
39. A major collagen-binding protein of chick embryo fibroblasts is a novel heat shock protein
40. Transformation of BALB/3T3 cells by simian virus 40 causes a decreased synthesis of a collagen-binding heat-shock protein (hsp47)
41. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA
42. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture
43. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8)
44. Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes
45. Expression of IL-1 genes in human and bovine chondrocytes: A mechanism for autocrine control of cartilage matrix degradation
46. Cytokines and inflammation in cartilage degradation
47. Approaches to rheumatoid arthritis and osteoarthritis: An overview
48. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns
49. Spontaneous and LPS-stimulated production of intracellular IL-1 beta by synovial macrophages in rheumatoid arthritis is inhibited by IFN-gamma
50. Specific serum antibodies against membranous proteins of a human immortal chondrocytic cell line (HCS-2/8) in rheumatoid arthritis and their relationship to the natural history of this disease
51. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage
52. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes
53. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells
54. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo
55. Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-Golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum
56. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide
57. Rheumatoid synovitis (problems of immunomorphology and immunopathogenesis)
58. Modulation of osteoclast differentiation by local factors
59. Rheumatoid arthritis and apoptosis
60. Effects of various growth factors on a chondrocyte differentiation model
61. Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis
62. The basic effect of IGF on chondrocytes
63. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8
64. Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan-rich cartilage-like nodules and to respond to insulin in vitro
65. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes
66. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: A possible mechanism of pathological neovascularization in arthritis
67. Modulation of cytokine function by heparan sulfate proteoglycans: Sophisticated models for the regulation of cellular responses to cytokines
68. Increased serum proMMP-3 in inflammatory arthritides: A potential indicator of synovial inflammatory monokine activity
69. Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: An 8 year followup study
70. Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage
71. Predictors of joint damage in rheumatoid arthritis
72. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
73. Transcriptional activation of the mouse HSP47 gene in mouse osteoblast MC3T3-E1 cells by TGF-beta 1
74. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis
75. Rheumatoid arthritis - Its present and future